 The only company mass produce Hyaluronic Acid by fermentation biotechnology in Taiwan. SciVision Biotech Inc., which is composed of an outstanding R&D team, was founded in the hinterland of Kaohsiung Harbor in spring 2001. Based on self-owned genetic transfer technique as well as high-tech equipments, SciVision successfully developed a non-traditional microbial fermentation technique to produce medical grade Hyaluronic Acid (HA) with high quality and high safety. In 2003 and 2009, SciVision was respectively awarded the “Leading Innovative Product Research and Development Program” by the Ministry of Economic Affairs, which affirmed SciVision as the leading company in medical grade HA field. The international quality certificates guarantee the safety of our products. From the point of safety, SciVision’s products had passed intact assessments including in vivo, in vitro and clinical test. Our factory complied with ISO 13485 & ISO 9001 quality management system as well as medical device GMP. Hya-Joint Synovial Fluid Supplement and Hya-Dermis Facial Dermal Implant were CE-marked and approved for medical device export permit by Department of Health, Executive Yuan and available for sale worldwide. Hya-Joint also got the medical device permit issued by the Department of Health, Executive Yuan and achieved 2008 National Biotechnology and Medical Care Quality Award in the Medical Appliance Category. Now, this product is eligible for health insurance reimbursement to serve and care Taiwan’s people through medical-care system. SciVision, which combines “science” and “vision”, reveals our vision to create a better future with science. Our corporate logo demonstrates an integrated concept of utilizing leading biotechnology as a basis to continuously research and develop new products. We have to be innovative and integrate with the latest biotechnology in the world. To create a better future, we have upgraded our technology to focus on the health and beauty fields, with the aim of improving joint degeneration and reducing facial aging. In the future, SciVision will expand the overseas markets including Asia, Europe, America, and Southeast Asia while Taiwan serves as the base of the R&D, production, and marketing. We strive to promote our Hyaluronic Acid medical products to the global market. |
News